ConductScience.org, home

Paper25035388

Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance.

Rabar S and 4 others. BMJ, 2014. Cited by 235 papers, by iCite.

Cite this record

ConductScience Library. Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance. Papers, record 25035388. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25035388

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Lipid modification and cardiovascular risk assessment for the primary and secondary prevention of cardiovascular disease: summary of updated NICE guidance.
PubMed
Journal
BMJ
PubMed
Year
2014
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
235
iCite
Relative citation ratio, by iCite
7.88
iCite
Revised in PubMed
2026-05-18
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rabar SSilvia
2Harker MMartin
3O'Flynn NNorma
4Wierzbicki ASAnthony S
5Guideline Development GroupGroup

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cardiovascular DiseasesMajor topic
Hydroxymethylglutaryl-CoA Reductase InhibitorsMajor topic
LipidsMajor topic
Risk AssessmentMajor topic
Anion Exchange Resins
Diabetes Complications
Diet
Fatty Acids, Omega-3
Fibric Acids
Glomerular Filtration Rate
Humans
Hyperlipidemias
Hypolipidemic Agents
Nicotinic Acids
Practice Guidelines as Topic
Primary Prevention
Renal Insufficiency, Chronic
Secondary Prevention

Source PubMed

Download CSV of topics

Comments and corrections1

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

KindPMIDTitleIn Papers
Comment in25186969NICE must do better at summarising and communicating evidence on statins.https://conductscience.org/library/papers/25186969

Source PubMed

Download CSV of comments and corrections

Cited by121

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 235 citations.

PMIDTitleJournalYearIn PapersSource
42432440Association Between Optimal Revascularization for Chronic Total Occlusion and Long-Term Outcomes in Patients With Heart Failure With or Without Type 2 Diabetes.J Am Heart Assoc2026https://conductscience.org/library/papers/42432440PubMed
42064873Clinical characteristics of patients with diabetic peripheral neuropathy: a retrospective descriptive study.Front Clin Diabetes Healthc2026https://conductscience.org/library/papers/42064873PubMed
42050529Synergistic effects of insulin resistance and revascularization completeness on prognosis in patients with coronary artery calcification.Cardiovasc Diabetol2026https://conductscience.org/library/papers/42050529PubMed
41987068Plasma homocysteine and cardiovascular outcomes in postmenopausal women with coronary heart disease: a retrospective cohort study.BMC Cardiovasc Disord2026https://conductscience.org/library/papers/41987068PubMed
41392353Combined clinical, metabolomic, and polygenic scores for cardiovascular risk prediction.Eur Heart J2025https://conductscience.org/library/papers/41392353PubMed
41238712The association between APOA1 levels and long-term outcomes in H-type hypertension with acute myocardial infarction patients: A retrospective cohort study.J Hum Hypertens2026https://conductscience.org/library/papers/41238712PubMed
40940402Serum lncRNA-ANRIL and creatinine clearance as cardiovascular risk factors in patients who underwent sleeve gastrectomy.Sci Rep2025https://conductscience.org/library/papers/40940402PubMed
40387056Prognostic impact of systemic inflammatory response index in patients with myocardial infarction with non-obstructive coronary arteries.Chin Med J (Engl)2025https://conductscience.org/library/papers/40387056PubMed
40303637The association between stress hyperglycemia ratio and 1-year outcomes in patients with acute myocardial infarction: a retrospective large sample cohort study.Front Endocrinol (Lausanne)2025https://conductscience.org/library/papers/40303637PubMed
40275234Reply to: What evidence is required to justify the NHS Health Check programme?BMC Med2025https://conductscience.org/library/papers/40275234PubMed
40102916Prognostic impact of prediabetes on long-term cardiovascular outcomes in patients under 35 with premature acute myocardial infarction.Diabetol Metab Syndr2025https://conductscience.org/library/papers/40102916PubMed
39534649Machine-learning-based prediction of cardiovascular events for hyperlipidemia population with lipid variability and remnant cholesterol as biomarkers.Health Inf Sci Syst2024https://conductscience.org/library/papers/39534649PubMed
39031184Effect of anti-diabetic agent on interstitial lung disease in patients with diabetes mellitus.Naunyn Schmiedebergs Arch Pharmacol2025https://conductscience.org/library/papers/39031184PubMed
39030064Risk estimation for the primary prevention of cardiovascular disease: considerations for appropriate risk prediction model selection.Lancet Glob Health2024https://conductscience.org/library/papers/39030064PubMed
38948897
The effect of fasting plasma glucose on in-hospital mortality after acute myocardial infarction in patients with and without diabetes: findings from a prospective, nationwide, and multicenter registry.
J Geriatr Cardiol2024https://conductscience.org/library/papers/38948897PubMed
38654927Free triiodothyronine to free thyroxine ratio as a marker of poor prognosis in euthyroid patients with acute coronary syndrome and diabetes after percutaneous coronary intervention.Front Endocrinol (Lausanne)2024https://conductscience.org/library/papers/38654927PubMed
38572097Construction and characterization of a humanized SLCO1B1 rat model with its application in evaluating the uptake of different statins.Acta Pharm Sin B2024https://conductscience.org/library/papers/38572097PubMed
38219904Indian dyslipidaemia guidelines: Need of the hour.Indian Heart J2024https://conductscience.org/library/papers/38219904PubMed
38200427Determinants of poor glycaemic control and proteinuria in patients with type 2 diabetes: a retrospective analysis of general practice records in Ireland.BMC Prim Care2024https://conductscience.org/library/papers/38200427PubMed
37979723Management of triglycerides, non-high density lipoprotein cholesterol and high density lipoprotein cholesterol.Indian Heart J2024https://conductscience.org/library/papers/37979723PubMed

See all 121 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/25035388

GET https://conductscience.org/api/papers/v1/25035388/cited_by?page=2